Concepedia
Statistics
Publications
29
Citations
1.7K
H-Index
21
Active since
1983
Affiliations
Research Triangle Park Foundation(Current)
Burroughs Wellcome Fund
Texas Tech University
Texas Tech University Health Sciences Center
Environmental Protection Agency
Greg C. Rigdon is an author at Research Triangle Park Foundation specializing in neuropharmacology, pharmacology, and medicine.
Publications per year
1983–2019
Efficacy and safety of the Gardos channel blocker, senicapoc (ICA-17043), in patients with sickle cell anemia
Kenneth I. Ataga, Wally R. Smith, Laura M. De Castro et al. · Blood · 2008 · 234 citations · Full text
Medicine, Hematology, Pharmacology +6
Effect of Linking Bridge Modifications on the Antipsychotic Profile of Some Phthalimide and Isoindolinone Derivatives
Mark H. Norman, Douglas J. Minick, Greg C. Rigdon · Journal of Medicinal Chemistry · 1996 · 189 citations · Full text
Medicine, Medicinal Chemistry, Pharmacology +17
A novel, potent and selective nonpeptidic delta opioid receptor agonist BW373U86.
K J Chang, Greg C. Rigdon, J. L. Howard et al. · Journal of Pharmacology and Experimental Therapeutics · 1993 · 162 citations
5-Hydroxytryptamine 1a receptor agonists block prepulse inhibition of acoustic startle reflex.
Greg C. Rigdon, John K. Weatherspoon · Journal of Pharmacology and Experimental Therapeutics · 1992 · 127 citations
Medicine, Pharmacology, Psychiatry +17
N-(6-Chloro-pyridin-3-yl)-3,4-difluoro-benzamide (ICA-27243): A Novel, Selective KCNQ2/Q3 Potassium Channel Activator
Alan D. Wickenden, Jeff Krajewski, Barry London et al. · Molecular Pharmacology · 2007 · 115 citations
Medicine, Neuroscience, Pharmacology +17
1–5 of 29